Larvol Delta - Arsenal-Bio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-AB1015-in-Development-as-a-Treatment-for-Ovarian-Cancer

AB-1015 - ArsenalBio

https://www.businesswire.com/news/home/20230105005145/en/ArsenalBio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-AB-1015-in-Development-as-a-Treatment-for-Ovarian-Cancer

Jan 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next